# ABL2

## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|FL    |2   |relevance in FL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source       |frequency (%)|
|:------:|:-------------:|:-------------:|
|FL    |GAMBL genomes|0.69         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |2.14            |0               |
|DLBCL |No  |No                   |0.00            |0               |
|FL    |No  |No                   |0.00            |0               |


> [!NOTE]
> First described in FL in 2023 by [Kalmbach S](https://pubmed.ncbi.nlm.nih.gov/37563306)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ABL2_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ABL2_protein_hg38.html)

![image](images/proteinpaint/ABL2_NM_007314.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/ABL2.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/ABL2_hg38.html)

![image](images/proteinpaint/ABL2.svg)
## ABL2 Expression
![image](images/gene_expression/ABL2_by_pathology.svg)
<!-- ORIGIN: russler-germainMutationsAssociatedProgression2023a -->
